Obesity trials in India
29 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- Ahmedabad, Mumbai, Pune, Trivandrum
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - Phase 3Taking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Ahmedabad, Chennai, Hyderabad, Indore, Mumbai, Pune, Trivandrum
- Age
- 18 years and over
- People
- 1,600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - Phase 3Not yet taking people in IndiaA Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
- Where
- Ansārinagar, Calicut, Kolkata, Ludhiana, Meerut, Surat
- Age
- 18 years and over
- People
- 330 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07922330 - Phase 3Taking peopleA Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Where
- Aligarh, Baroda, Guntur, Hubli, Jaipur, Mysore, Nagpur, Trivandrum, Vellore
- Age
- 18 years and over
- People
- 2,001 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07794579 · EU 2026-526175-35-00 - Phase 3Taking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Where
- Bangalore
- Age
- 18 years and over
- People
- 1,035 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07282600 · EU 2025-523658-15-00 - Phase 3Taking peopleA Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Where
- Bengaluru, Bhubaneswar, Guntur, Nagpur, New Delhi, Pune, Raipur, Rishikesh, Thane, Vadodara
- Age
- 18 years and over
- People
- 800 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07369011 · EU 2025-523769-11-00 - Phase 3Taking peopleA Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Where
- Allahabād, Bangalore, Chennai, Hyderabad, Jaipur, Kanpur, Kolhāpur, Mysore, Nagpur, Surat
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07392190 · EU 2025-523659-73-00 - Phase 3Not yet taking people in IndiaA Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
- Where
- Ahmedabad, Baroda, Belagavi, Chennai, Guntur, Hubli, Kanpur, Noida, Pune, Raipur, Udaipur, Vellore
- Age
- 18 years and over
- People
- 2,115 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07881432 · EU 2026-526047-34-00 - Phase 3Not yet taking people in IndiaA Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
- Where
- Belagavi, Guntur, Guwahati, Mumbai, Nagpur, Pune, Rishikesh, Surat
- Age
- 45 years to 64 years
- People
- 3,000 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07900633 · EU 2026-525919-14-00 - Phase 3Taking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Where
- Bhubaneswar, Coimbatore, Hyderabad, Indore, Jaipur, Jodhpur, Kochi, Kolkata, Noida, Pune, Siliguri, Surat, Vijayawada
- Age
- 18 years and over
- People
- 2,500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00 - Phase 3Taking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Where
- Bangalore, Indore, Kolkata, Nagpur, Noida, Pune, Siliguri, Visakhapatnam
- Age
- 18 years and over
- People
- 1,500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784270 - Phase 3Taking peopleA Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- Where
- Bangalore, Belagavi, Bikaner, Delhi, Guntur, Hyderabad, Jaipur, Jodhpur, Kolkata, Madurai, Mumbai, Mysore, Nagpur, New Delhi, Siliguri
- Age
- 18 years and over
- People
- 4,500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07667803 - Phase 3Taking peopleAMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Where
- Bengaluru, Bhubaneswar, Delhi, Guntur, Hyderabad, Jaipur, Kochi, Kolkata, Lucknow, Mumbai, Nagpur, New Delhi, Vijayawada
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07571109 · EU 2024-520443-16-00 - Phase 3Not yet taking people in IndiaA Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
- Where
- Agra, Ahmedabad, Aligarh, Amritsar, Belagavi, Bhubaneswar, Chhatrapati Sambhajinagar, Dehradun, Faridabad, Gujarat, Guntur, Gurugram, Hyderabad, Indore, Jaipur, Kanpur, Karad, Kochi, Kolhāpur, Kolkata, Kozhikode, Lucknow, Manipal, Meerut, Mohali, Mumbai, Mysore, Nagpur, Nashik, New Delhi, Panjagutta, Prayagraj, Pune, Raipur, Rajinder Nagar, Surat, Vadodara, Varanasi, Vellore, Vijayawada
- Age
- 45 years to 64 years
- People
- 8,500 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07861100 · EU 2026-525182-53-00 - Phase 3Taking peopleA Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Where
- Bangalore, Delhi, Guntur, Kanpur, Kolhāpur, Kolkata, New Delhi, Surat
- Age
- 8 years to 18 years
- People
- 460 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07253285 · EU 2023-509176-42-00 - Phase 3Taking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Where
- Guntur, Guwahati, Hyderabad, Mandya, Mumbai, Mysore, Nagpur, Nashik, Pune, Trichy
- Age
- 18 years and over
- People
- 1,980 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00 - Phase 3Taking peopleAMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- Where
- Bengaluru, Bhubaneswar, Delhi, Guntur, Hyderabad, Jaipur, Kochi, Kolkata, Lucknow, Mumbai, Nagpur, New Delhi, Vijayawada
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07571005 · EU 2024-520442-36-00 - Phase 3Not yet taking people in IndiaAMAZE 13: A Research Study Investigating How Well the Medicine Zenagamtide Helps People in Asia With Excess Body Weight Lose Weight
- Where
- Assam, Chennai, Delhi, Hubbali, Hyderabad, Indore, Jaipur, Kohlapur, Kolhāpur, Kozhikode, Mumbai, Nagpur, Nashik, Pune, Surat, Vadodara, Vellore
- Age
- 18 years and over
- People
- 400 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07668401 - Phase 3Taking peopleA Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- Where
- Aligarh, Bangalore, Belagavi, Bhubaneswar, Chennai, Coimbatore, Dehradun, Durgapur, Guntur, Gurgaon, Gurugram, Hubbali, Hyderabad, Indore, Kanpur, Karad, Kochi, Lucknow, Ludhiana, Mohali, Mumbai, Mysuru, Nagpur, Nashik, New Dehli, New Delhi, Pune, Raipur, Udham Singh Nagar, Vadodara, Varanasi, Vijayawada
- Age
- 18 years and over
- People
- 5,610 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07567001 · EU 2025-523717-29-00 - Phase 4Taking peopleFibrosis Lessens After Metabolic Surgery
- Where
- Indore, Mumbai
- Age
- 18 years to 75 years
- People
- 120 worldwide
- Run by
- The Cleveland Clinic
See details and how to joinNCT06374875 - No phaseTaking peopleKodo Millet Porridge and Its Effects on Gut Health and Metabolic Syndrome
- Where
- Mysore
- Age
- 20 years to 60 years
- People
- 50
- Run by
- JSS MEDICAL COLLEGE, JSS ACADEMY OF HIGHER EDUCATION AND RESEARCH
See details and how to joinNCT07703371 - Phase 4Taking peopleEvaluation of Propofol Dosing Based on Total Body Weight Using Closes-loop Anaesthesia Delivery System
- Where
- New Delhi
- Age
- 18 years to 65 years
- People
- 46
- Run by
- Sir Ganga Ram Hospital
See details and how to joinNCT05305313 - Phase 2Taking peopleEfficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
- Where
- Bangalore, Chennai, Guntur, Kolhāpur, Kozhikode, Mumbai, New Delhi, Pune, Trivandrum
- Age
- 18 years and over
- People
- 285 worldwide
- Run by
- Sun Pharmaceutical Industries Limited
See details and how to joinNCT07282743 - Phase 2Taking peopleA Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
- Where
- Bengaluru, Guntur, Hyderabad, Jaipur, Kozhikode
- Age
- 18 years and over
- People
- 465 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT06717698 · EU 2024-510846-15-00 - No phaseTaking peopleComorbidities Resolution After MGB Surgery and Change in Body Composition
- Where
- Bhubaneswar
- Age
- 18 years to 65 years
- People
- 35
- Run by
- All India Institute of Medical Sciences, Bhubaneswar
See details and how to joinNCT06015620